Patrick J. Beyer

Patrick J. Beyer

DirectoratCONMED· In proxies 2021–2025

Pay in FY2025+78% from the year before

Patrick J. Beyer was paid $7.6M in FY2025 (Dec), up 78%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each CONMED proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. BioventusPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  2. CONMEDPublic company · 5 yr
    • President and Chief Executive Officer2021 – Present · 5 yrNo stock prices for these years
  3. Audit and Risk CommitPublic company
    • Director? – PresentNo stock prices for these years
  4. Bioventus Inc. (Nasdaq: BVS), Since 2021Public company
    • Director? – PresentNo stock prices for these years
  5. Misonix, Inc.Public company · Less than 1 yr
    • Director2021 – 2021 · Less than 1 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • CONMEDDirector · -1 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?